Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.1% |
| 2 | Technology | 1.55% |
| 3 | Consumer Discretionary | 0.95% |
| 4 | Financials | 0.77% |
| 5 | Healthcare | 0.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11376
Nuveen Multi-Asset Income Fund
NMAI
$483M
| $124K | ﹤0.01% |
+10,352
| New | +$127K |
|
11377
Wheels Up
UP
$178M
| $124K | ﹤0.01% |
6,158
-2,863
| -32% | -$78.8K |
|
|
CUB
11378
Lionheart Holdings
CUB
$284M
| $124K | ﹤0.01% |
12,095
-6,199
| -34% | -$63.1K |
|
11379
Lipocine
LPCN
$18.1M
| $124K | ﹤0.01% |
38,980
+13,975
| +56% | +$54.1K |
|
11380
Drilling Tools International
DTI
$88.2M
| $124K | ﹤0.01% |
+52,163
| New | +$161K |
|
|
BRSP
11381
CALL
BrightSpire Capital
BRSP
$605M
| $123K | ﹤0.01% |
22,200
-53,500
| -71% | -$313K |
|
11382
eGain
EGAN
$206M
| $123K | ﹤0.01% |
25,437
+7,372
| +41% | +$41.7K |
|
|
NOTE
11383
CALL
DELISTED
FiscalNote
NOTE
| $123K | ﹤0.01% |
12,692
+4,934
| +64% | +$74.2K |
|
|
PHT
11384
DELISTED
Pioneer High Income Fund
PHT
| $123K | ﹤0.01% |
+15,934
| New | +$125K |
|
11385
TROOPS Inc
TROO
$275M
| $123K | ﹤0.01% |
+163,649
| New | +$226K |
|
|
CGAU
11386
CALL
Centerra Gold
CGAU
$4.63B
| $123K | ﹤0.01% |
19,400
-16,300
| -46% | -$99.6K |
|
|
MQT
11387
DELISTED
BlackRock MuniYield Quality Fund II
MQT
| $123K | ﹤0.01% |
12,302
-3,648
| -23% | -$37K |
|
11388
PUT
Regenxbio
RGNX
$625M
| $123K | ﹤0.01% |
+17,200
| New | +$128K |
|
11389
CALL
AerSale
ASLE
$269M
| $123K | ﹤0.01% |
16,400
+1,500
| +10% | +$10.7K |
|
|
MVF
11390
DELISTED
BlackRock MuniVest Fund
MVF
| $123K | ﹤0.01% |
+17,521
| New | +$126K |
|
|
SEPN
11391
PUT
Septerna Inc
SEPN
$1.84B
| $123K | ﹤0.01% |
+21,200
| New | +$242K |
|
11392
Adaptive Hedged Multi-Asset Income ETF
AMAX
$70.2M
| $122K | ﹤0.01% |
+16,532
| New | +$128K |
|
11393
Cumberland Pharmaceuticals
CPIX
$134M
| $122K | ﹤0.01% |
+28,939
| New | +$120K |
|
11394
CALL
CVRx
CVRX
$80.5M
| $122K | ﹤0.01% |
10,000
-700
| -7% | -$9.89K |
|
11395
Jerash Holdings
JRSH
$70.4M
| $122K | ﹤0.01% |
35,949
+23,369
| +186% | +$83K |
|
|
AMRN
11396
Amarin Corp
AMRN
$296M
| $122K | ﹤0.01% |
13,636
-3,292
| -19% | -$34.8K |
|
11397
Acumen Pharmaceuticals
ABOS
$213M
| $122K | ﹤0.01% |
110,976
+35,088
| +46% | +$50.1K |
|
|
AVK
11398
Advent Convertible and Income Fund
AVK
$557M
| $122K | ﹤0.01% |
10,587
-7,628
| -42% | -$91.1K |
|
11399
PUT
Editas Medicine
EDIT
$516M
| $122K | ﹤0.01% |
105,100
+28,600
| +37% | +$42.1K |
|
|
AMDG
11400
Leverage Shares 2X Long AMD Daily ETF
AMDG
$24.4M
| $122K | ﹤0.01% |
+12,394
| New | +$139K |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q1 2025 filing shows 1,775 new, 5,712 increased, 4,842 reduced and 1,482 closed positions. Its largest new stake was Brookfield Asset Management: 1,775,684 shares worth $86M. The largest sale was Invesco QQQ Trust, an estimated $1.25B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.